CVS Health CVS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 44.7%-0.3pp | 45%+0.2pp | 44.8%0.0pp | 44.8%+0.1pp | 44.8%+0.1pp | |
| Operating margin | 1.5%+0.3pp | 1.2%-0.1pp | 1.2%-1.1pp | 2.3%-0.2pp | 2.5%+0.3pp | |
| Net margin | 0.7%+0.3pp | 0.4%+0.3pp | 0.1%-1.1pp | 1.2%-0.2pp | 1.4%+0.2pp | |
| EBITDA margin | 2.6%+0.3pp | 2.3%-0.1pp | 2.4%-1.1pp | 3.5%-0.2pp | 3.8%+0.2pp | |
| Free cash flow margin | 1.8%-0.1pp | 1.9%+0.3pp | 1.6%— | —— | —— | |
| Returns | ||||||
| Return on equity | 3.8%+1.5pp | 2.3%+1.7pp | 0.6%-5.3pp | 5.9%-1.0pp | 7%+0.9pp | |
| Return on assets | 1.2%+0.5pp | 0.7%+0.5pp | 0.2%-1.6pp | 1.8%-0.3pp | 2.1%+0.3pp | |
| Return on invested capital | 7.1%+3.2pp | 3.9%+2.3pp | 1.6%-3.7pp | 5.3%-3.0pp | 8.3%+4.1pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×0.0× | 1.6×0.0× | 1.6×0.0× | 1.5×0.0× | 1.5×0.0× | |
| Inventory turnover | 12.8×+1.0× | 11.8×0.0× | 11.9×-0.9× | 12.7×+0.3× | 12.4×+1.0× | |
| Liquidity | ||||||
| Current ratio | 0.9×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Quick ratio | 0.7×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Cash ratio | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×-0.9× | 1.2×+0.9× | 0.2×0.0× | 0.2×-0.9× | |
| Debt-to-assets | 0.1×0.0× | 0.1×-0.3× | 0.3×+0.3× | 0.1×0.0× | 0.1×-0.3× | |
| Net debt / EBITDA | 0.5×-0.3× | 0.9×-7.0× | 7.9×+7.3× | 0.5×0.0× | 0.5×-5.4× | |
| Interest coverage | 1.9×+0.4× | 1.5×-0.1× | 1.6×-1.3× | 2.9×-0.2× | 3.2×+0.3× | |
| Per Share | ||||||
| Book value per share | $60.56+2.3% | $59.18+3.0% | $57.47-5.7% | $60.93+0.1% | $60.86+1.7% | |
| Valuation | ||||||
| Market capitalization | $91.37B-9.3% | $100.74B+5.4% | $95.62B+11.8% | $85.49B+0.1% | $85.42B+51.2% | |
| Enterprise value | $96.84B-10.9% | $108.74B-36.3% | $170.62B+84.0% | $92.74B-0.1% | $92.83B-30.7% | |
| Price / earnings | 31.2×-25.8× | 57×-147× | 203.9×+185× | 18.9×+2.7× | 16.2×+3.9× | |
| Price / sales | 0.2×0.0× | 0.3×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.1× | |
| Price / book | 1.2×-0.2× | 1.3×0.0× | 1.3×+0.2× | 1.1×0.0× | 1.1×+0.4× | |
| EV / EBITDA | 9.2×-2.5× | 11.7×-6.2× | 17.9×+11.1× | 6.8×+0.3× | 6.5×-3.7× | |
| EV / sales | 0.2×0.0× | 0.3×-0.2× | 0.4×+0.2× | 0.2×0.0× | 0.2×-0.1× | |
| Free cash flow yield | 8.1%+0.3pp | 7.7%+1.2pp | 6.6%— | —— | —— | |
| Earnings yield | 3.2%+1.5pp | 1.8%+1.3pp | 0.5%-4.8pp | 5.3%-0.9pp | 6.2%-2.0pp | |
| Dividend yield | 3.7%+0.4pp | 3.4%-0.2pp | 3.5%-0.4pp | 4%0.0pp | 3.9%-2.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CVS Health's profit margins?
- CVS Health (CVS) runs a 44.7% gross margin and a 1.5% operating margin, with a 0.7% net margin.
- Where do CVS Health's ratios come from?
- Every ratio is computed from CVS Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
